Halliburton (NYSE:HAL – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty research firms that are presently covering the company, Marketbeat reports. Four analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $40.58.
A number of equities analysts recently weighed in on the stock. Barclays cut their price target on shares of Halliburton from $47.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 8th. The Goldman Sachs Group reduced their target price on shares of Halliburton from $47.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. BMO Capital Markets lowered their price target on shares of Halliburton from $40.00 to $38.00 and set a “market perform” rating on the stock in a report on Thursday, October 10th. UBS Group lowered Halliburton from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $36.00 to $34.00 in a report on Monday, December 9th. Finally, Jefferies Financial Group lowered their target price on Halliburton from $47.00 to $46.00 and set a “buy” rating on the stock in a research note on Tuesday, September 24th.
Check Out Our Latest Analysis on Halliburton
Institutional Investors Weigh In On Halliburton
Halliburton Trading Down 0.7 %
NYSE:HAL opened at $28.68 on Friday. Halliburton has a 52 week low of $27.26 and a 52 week high of $41.56. The firm has a 50-day moving average price of $29.75 and a two-hundred day moving average price of $31.31. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.62 and a current ratio of 2.21. The firm has a market cap of $25.20 billion, a price-to-earnings ratio of 9.99, a price-to-earnings-growth ratio of 3.61 and a beta of 1.90.
Halliburton (NYSE:HAL – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The oilfield services company reported $0.73 EPS for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.02). The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.83 billion. Halliburton had a return on equity of 28.33% and a net margin of 11.04%. The business’s revenue was down 1.8% compared to the same quarter last year. During the same quarter last year, the business posted $0.79 earnings per share. On average, equities analysts expect that Halliburton will post 3 earnings per share for the current fiscal year.
Halliburton Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 26th. Stockholders of record on Wednesday, December 4th will be paid a dividend of $0.17 per share. The ex-dividend date is Wednesday, December 4th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 2.37%. Halliburton’s dividend payout ratio (DPR) is currently 23.69%.
Halliburton Company Profile
Halliburton Company provides products and services to the energy industry worldwide. It operates through two segments, Completion and Production, and Drilling and Evaluation. The Completion and Production segment offers production enhancement services that include stimulation and sand control services; cementing services, such as well bonding and casing, and casing equipment; and completion tools that offer downhole solutions and services, including well completion products and services, intelligent well completions, and service tools, as well as liner hanger, sand control, and multilateral systems.
Read More
- Five stocks we like better than Halliburton
- What is a Low P/E Ratio and What Does it Tell Investors?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Halliburton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halliburton and related companies with MarketBeat.com's FREE daily email newsletter.